{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:03:18Z","timestamp":1789401798801,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013318","name":"Shanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2022XM11"],"award-info":[{"award-number":["2022XM11"]}],"id":[{"id":"10.13039\/501100013318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004480","name":"Shanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["202403021221195"],"award-info":[{"award-number":["202403021221195"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.phrs.2026.108370","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:18:04Z","timestamp":1786022284000},"page":"108370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of glucose-lowering agents with readmission risk in patients with rheumatoid arthritis and comorbid type 2 diabetes mellitus"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-8743","authenticated-orcid":false,"given":"Junfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.phrs.2026.108370_bib1","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","article-title":"The pathogenesis of rheumatoid arthritis","volume":"55","author":"Alivernini","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2026.108370_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1051082","article-title":"Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108370_bib3","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","article-title":"Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017","volume":"78","author":"Safiri","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2026.108370_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/kex414","article-title":"High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data","volume":"57","author":"Albrecht","year":"2018","journal-title":"Rheumatol. (Oxf. )"},{"issue":"34","key":"10.1016\/j.phrs.2026.108370_bib5","article-title":"Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study","volume":"96","author":"Ruscitti","year":"2017","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.phrs.2026.108370_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1445639","article-title":"Risk factors for type 2 diabetes mellitus in Chinese rheumatoid arthritis patients from 2018 to 2022: a real-world, single-center, retrospective study","volume":"15","author":"Pei","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108370_bib7","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/acr.25537","article-title":"Metabolic Consequences of Rheumatoid Arthritis","volume":"77","author":"Barry","year":"2025","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"9","key":"10.1016\/j.phrs.2026.108370_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.246","article-title":"The interplay between inflammation and metabolism in rheumatoid arthritis","volume":"6","author":"Chimenti","year":"2015","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.phrs.2026.108370_bib9","article-title":"Crossing the metabolic homeostasis divide: panoramic decoding of therapeutic targets for metabolic-inflammatory crosstalk in rheumatoid arthritis","volume":"16","author":"Liang","year":"2025","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.phrs.2026.108370_bib10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/cells14130964","article-title":"Insulin Predicts Methotrexate Response by Affecting the Transcription of Methotrexate Target Genes in the Treatment-Naive Rheumatoid Arthritis","volume":"14","author":"Lundgren","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108370_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152727","article-title":"Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure","volume":"73","author":"Chandrupatla","year":"2025","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.phrs.2026.108370_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2022.1050579","article-title":"Clinical risk factors and social needs of 30-day readmission among patients with diabetes: A retrospective study of the Deep South","volume":"3","author":"McDaniel","year":"2022","journal-title":"Front. Clin. Diabetes Healthc."},{"issue":"6","key":"10.1016\/j.phrs.2026.108370_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/annrheumdis-2019-216243","article-title":"Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era","volume":"79","author":"Hsieh","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.108370_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155223","article-title":"Metformin: Is it a drug for all reasons and diseases?","volume":"133","author":"Triggle","year":"2022","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib15","article-title":"The direct and indirect inhibition of proinflammatory adipose tissue macrophages by acarbose in diet-induced obesity","volume":"6","author":"Li","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.phrs.2026.108370_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1643676","article-title":"Metformin attenuates alveolar bone destruction in mice with apical periodontitis and inhibits pro-inflammatory cytokine synthesis in lipopolysaccharide-stimulated RAW264.7 through the AMPK-mTOR-NF-\u03baB pathway","volume":"16","author":"Ren","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108370_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41584-021-00585-3","article-title":"The gut-joint axis in rheumatoid arthritis","volume":"17","author":"Zaiss","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2026.108370_bib18","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3389\/fphar.2019.01684","article-title":"Alpha-Glucosidase Inhibitors Alter Gut Microbiota and Ameliorate Collagen-Induced Arthritis","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5273(02)00237-1","article-title":"Cachexia in rheumatoid arthritis","volume":"85","author":"Walsmith","year":"2002","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108370_bib20","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s10067-022-06122-1","article-title":"Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study","volume":"41","author":"Xu","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12944-023-01899-9","article-title":"The association between triglyceride glucose index and arthritis: a population-based study","volume":"22","author":"Yan","year":"2023","journal-title":"Lipids Health Dis."},{"issue":"8","key":"10.1016\/j.phrs.2026.108370_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0308533","article-title":"Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study","volume":"19","author":"Karacabeyli","year":"2024","journal-title":"PLoS. ONE"},{"issue":"3","key":"10.1016\/j.phrs.2026.108370_bib23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/acr.24866","article-title":"Reduction of Cardiovascular Disease and Mortality Versus Risk of New-Onset Diabetes Mellitus With Statin Use in Patients With Rheumatoid Arthritis","volume":"75","author":"Ozen","year":"2023","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ije\/dyu222","article-title":"Modelling recurrent events: a tutorial for analysis in epidemiology","volume":"44","author":"Amorim","year":"2015","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib25","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41598-022-26933-1","article-title":"Longitudinal individual predictions from irregular repeated measurements data","volume":"13","author":"Eekhout","year":"2023","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.phrs.2026.108370_bib26","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib27","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33 1","author":"Association","year":"2010","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.phrs.2026.108370_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102612","article-title":"Rhupus: a systematic literature review","volume":"19","author":"Antonini","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2026.108370_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/M22-2904","article-title":"Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update","volume":"176","author":"Navaneethan","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2026.108370_bib30","doi-asserted-by":"crossref","DOI":"10.2196\/53719","article-title":"Handling Missing Data in COVID-19 Incidence Estimation: Secondary Data Analysis","volume":"10","author":"Pham","year":"2024","journal-title":"JMIR Public. Health Surveill."},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/ard-2022-223358","article-title":"Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"82","author":"Bergstra","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2026.108370_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41584-023-00944-2","article-title":"Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19","volume":"19","author":"Cutolo","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib33","first-page":"S158","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.phrs.2026.108370_bib34","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"issue":"15","key":"10.1016\/j.phrs.2026.108370_bib35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMp2113319","article-title":"Methods of Public Health Research - Strengthening Causal Inference from Observational Data","volume":"385","author":"Hern\u00e1n","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.phrs.2026.108370_bib36","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1177\/0962280220921889","article-title":"A tutorial on frailty models","volume":"29","author":"Balan","year":"2020","journal-title":"Stat. Methods Med. Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13075-025-03495-x","article-title":"The rational use of glucocorticoids may reduce the risk of readmission in menopausal women with knee osteoarthritis: results from a five-year longitudinal study","volume":"27","author":"Xi","year":"2025","journal-title":"Arthritis Res. Ther."},{"issue":"20","key":"10.1016\/j.phrs.2026.108370_bib38","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1080\/03610926.2011.638428","article-title":"Modeling of Inverse Gaussian Frailty Model for Bivariate Survival Data","volume":"42","author":"Hanagal","year":"2013","journal-title":"Commun. Stat. - Theory Methods"},{"issue":"3","key":"10.1016\/j.phrs.2026.108370_bib39","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1080\/02664763.2020.1828314","article-title":"Survival analysis for the inverse Gaussian distribution with the Gibbs sampler","volume":"49","author":"Jayalath","year":"2022","journal-title":"J. Appl. Stat."},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40096-020-00366-1","article-title":"A comparative study with bootstrap resampling technique to uncover behavior of unconditional hazards and survival functions for gamma and inverse Gaussian frailty models","volume":"15","author":"Ata Tutkun","year":"2021","journal-title":"Math. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s10985-021-09540-6","article-title":"An additive hazards frailty model with semi-varying coefficients","volume":"28","author":"Zhang","year":"2022","journal-title":"Lifetime Data Anal."},{"issue":"10","key":"10.1016\/j.phrs.2026.108370_bib42","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108370_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041535","article-title":"Sex and Gender Aspects for Patient Stratification in Allergy Prevention and Treatment","volume":"21","author":"De Martinis","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13075-020-02174-3","article-title":"Metformin rescues rapamycin-induced mitochondrial dysfunction and attenuates rheumatoid arthritis with metabolic syndrome","volume":"22","author":"Kim","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2026.108370_bib45","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3390\/jcm12072461","article-title":"Metformin Treatment Reduces the Incidence of Rheumatoid Arthritis: A Two-Sample Mendelian Randomized Study","volume":"12","author":"Liang","year":"2023","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.108370_bib46","article-title":"Causal association of metformin treatment with diverse immune-mediated inflammatory diseases: A Mendelian randomization analysis","volume":"104","author":"Liao","year":"2025","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.phrs.2026.108370_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.726490","article-title":"Efficacy and Safety of Metformin Use in Rheumatoid Arthritis: A Randomized Controlled Study","volume":"12","author":"Gharib","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108370_bib48","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/rheumatology\/ken146","article-title":"Rheumatoid cachexia: a clinical perspective","volume":"47","author":"Summers","year":"2008","journal-title":"Rheumatol. (Oxf. )"},{"issue":"1","key":"10.1016\/j.phrs.2026.108370_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000327","article-title":"Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes","volume":"2","author":"DiNicolantonio","year":"2015","journal-title":"Open. Heart"},{"issue":"4","key":"10.1016\/j.phrs.2026.108370_bib50","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ando.2023.05.002","article-title":"Metabolic complications of glucocorticoids - Prevention by metformin","volume":"84","author":"Sanpawithayakul","year":"2023","journal-title":"Ann. Endocrinol. (Paris. )"},{"issue":"9","key":"10.1016\/j.phrs.2026.108370_bib51","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41574-022-00683-6","article-title":"Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108370_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0328094","article-title":"Medical costs for patients with rheumatoid arthritis who have comorbid diabetes mellitus","volume":"20","author":"Tanaka","year":"2025","journal-title":"PLoS. ONE"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:08:16Z","timestamp":1789398496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826002859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"alternative-id":["S1043661826002859"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108370","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of glucose-lowering agents with readmission risk in patients with rheumatoid arthritis and comorbid type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108370"}}